Adynxx

Adynxx ROA

The Return on Assets (ROA) of Adynxx (ADYX) as of Nov 4, 2026 is -86.96 %. In the previous year, Return on Assets (ROA) was -78.04 % — a change of 11.43% (lower).

ROA

-86.96 %

YoY

11.43%

Last updated:

In 2018, Adynxx's return on assets (ROA) was -86.96 %, a 11.43% increase from the -78.04 % ROA in the previous year.

The Adynxx ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2014
-85.61 USD
Jan 1, 2015
-28.99 USD
Jan 1, 2016
-51.82 USD
Jan 1, 2017
-78.04 USD
Jan 1, 2018
-86.96 USD
The Adynxx ROA history
YEARROAYoY
-86.96 %+11.43%
-78.04 %+50.59%
-51.82 %+78.78%
-28.99 %-66.14%
-85.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Adynxx Stock analysis

What does Adynxx do? Adynxx Inc. is a biotechnology company focused on the development of novel, non-opioid-based pain therapies. The company was founded in 2007 in San Francisco, California, and has since pursued ambitious goals in the field of pain treatment. Adynxx has raised over $65 million in investments since its inception and has an experienced team of experts from the pharmaceutical industry, academic researchers, and business professionals. The company's business model is based on offering non-opioid pain therapy based on the blocking of the Kv1.7 protein. Adynxx aims to use this therapy in various areas such as surgery, acute pain management, and chronic pain treatment. The company employs an agile approach to clinical studies, allowing for quick adaptation to new insights and optimization of the effectiveness and safety of pain treatment. Adynxx operates in three areas: surgery, acute pain management, and chronic pain. Each division aims to provide pain patients with an effective alternative to opioid-based pain medications. The product line includes various non-opioid analgesics based on the blocking of the Kv1.7 protein. The flagship product, AYX1, is currently in Phase II clinical trials. It is an injection administered before or during surgery to relieve pain and offers up to 72 hours of pain relief. Another product in development is AYX2, intended for the treatment of chronic pain. Adynxx has the potential to fundamentally change pain treatment and provide a safe alternative to opioid-based pain medications, offering pain patients effective, safe, and sustainable relief and contributing to an improvement in quality of life. Adynxx is one of the most popular companies on Eulerpool.

ROA Details

Understanding Adynxx's Return on Assets (ROA)

Adynxx's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Adynxx's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Adynxx's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Adynxx’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Adynxx stock

Return on Assets (ROA) of Adynxx is -86.96 % in 2018.

Return on Assets (ROA) of Adynxx changed from -78.04 % to -86.96 %, representing a 11.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Adynxx since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Adynxx with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Adynxx

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Adynxx